Overview Fundamentals API Earnings EOD API Sample Code Pricing

CARDERO RESOURCE (CR5 F) stock market data APIs

€11 0(0%) as of October 8, 2024
Price chart is built with Anychart

Oculis Holding AG, a clinical-stage biopharmaceutical company, develops drug candidates to treat ophthalmic diseases. The company's lead product candidate is OCS-01, a topical dexamethasone optireach formulation, which is in Phase 3 clinical trials for the treatment of diabetic macular edema; OCS-02, a topical biologic candidate that is in Phase 2b clinical trials for the treatment for dry eye disease; and OCS-05, a disease modifying neuroprotective agent for neurological damage with indications for glaucoma, dry age-related macular degeneration and diabetic retinopathy, and acute optic neuritis. The company is based in Zug, Switzerland.

CARDERO RESOURCE Financial Data Overview

11
11
-
11
11
8.65-12.6
662 M
41 745 K
871 K
0.086
Our easy-to-use no-coding solutions help you get the data effortlessly:

No long-term obligations. The minimum period is one month only. No wait. You get an API key with instructions in a few seconds right after subscription.

General: {
Code: 'CR5',
Type: 'Common Stock',
Name: 'CARDERO RESOURCE',
Exchange: 'F',
CurrencyCode: 'EUR',
CurrencyName: 'Euro',
CurrencySymbol: '€',
CountryName: 'Germany',
CountryISO: 'DE',
OpenFigi: NULL,
ISIN: NULL,
CIK: NULL,
EmployerIdNumber: NULL,
FiscalYearEnd: 'December',
IPODate: NULL,
InternationalDomestic: NULL,
Sector: 'Healthcare',
Industry: 'Biotechnology',
}

CARDERO RESOURCE Fundamental Data is available in our Financial Data APIs

  • Net Revenue 871 K
  • EBITDA -62 840 000
  • Earnings Per Share -1.49
  • Income Statements
  • Balance Sheets
  • Cash flows
Get sample
of Fundamental API Data

Get CARDERO RESOURCE Earnings via APIs

  • Latest Release NaN
  • EPS/Forecast NaN

Get CARDERO RESOURCE End-of-day Data via APIs

  • End of Day, Intraday and Live APIs
  • Splits
  • Dividends
Do you have any questions?
support@eodhistoricaldata.com